The RNA Leaders World Congress delivers the latest advances in RNA chemistry, clinical updates, new therapies and the services partners who are helping to deliver drugs to patients. RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic. But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful. Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging.

With that in mind, we can’t wait to bring the community together, face-to-face, for the second annual RNA Leaders Europe Congress. So, if you’re passionate about all things RNA do join us, and more than 600 biotech, pharmaceutical, investment, regulatory and scientific professionals at the RNA Leaders Europe Congress. You’ll hear the latest advances in RNA chemistry, get clinical updates from the companies developing new therapies and source the services partners who are helping to deliver drugs to patients.

Read on lsxleaders.com

Continue reading at lsxleaders.com

Leadership Therapeutics

Facebook Share

Twitter Share

Linkedin Share

Email Share